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Abstract
Objective.—The objective of this study is to estimate consumers’ maximum willingness-to-pay 
(WTP) for follow-up PID services by physicians and community health nurses (CHNs), 
differences by consumer type (adolescents versus parents), and the differences in health-provider 
predicted WTP consumer estimates and actual consumer WTP estimates.
Methods.—In this IRB-approved study, a contingent valuation method was used to collect WTP 
data regarding co-payments to physicians or nurses for clinical service delivery from the 
consumers of adolescent PID services (parents and adolescents) and health providers using a 
national convenience sample. Consumers were recruited from an academic pediatric and 
adolescent medicine clinic and five health department school-based health clinics in a large urban 
community with high (sexually transmitted infection) STI prevalence. Participants completed a 
web-based survey. Data were analyzed using linear regression analyses.
Results.—Adolescents were willing to pay $36 more (95 % Cl : $27.9–44.3) for community 
health nursing care and parents were willing to pay $48 more dollars (95 % Cl : $40.3-$57.4) than 
physician’s predicted. There were no significant differences in adolescent and parents WTP for 
physician or nursing services Consumers (adolescents & parents) WTP for physician PID services 
were on average $18.50 higher than CHN PID services (p = 0.01). Using physician estimates for 
WTP as the reference group, adolescents were willing to pay $56 more (95 % Cl : $48.6-$63.4) 
for physician care and parents were willing to pay $66 more (95 % Cl : $59.0-$72.8) than 
physician’s predicted.
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Conclusion.—Adolescents and parents are willing to pay more for physician follow-up for PID, 
but they are open to CHN follow-up visits based on the mean WTP for CHN visits. Since WTP 
also reflects the value that individuals place on a service, our data demonstrate that providers 
consistently underestimate the value consumers place on clinical services for x adolescents with 
PID.
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Pelvic inflammatory disease (PID) is a common reproductive health disorder that 
disproportionately affects adolescent and young adult women [1] and puts the affected 
patient at risk for ectopic pregnancy, chronic pelvic pain, and infertility [2–4], While the 
rates of PID have declined over the last 15 years due to asymptomatic screening and early 
treatment of sexually transmitted infections (STIs) [5], treatment of the adolescent with PID 
has shifted from inpatient to outpatient settings in an effort to further contain the costs of 
PID care. This shift was supported by studies demonstrating the effectiveness of oral 
antibiotic regimens [6, 7] and subsequent findings from the PID Evaluation and Clinical 
Health (PEACH) trial, a large multi-center trial comparing the efficacy of inpatient and 
outpatient treatment in the United States. Given the low cost of oral medications, low 
clinical utilization after initial treatment [8], and the historic unmet need for fertility services 
in the United States [9]; it is not surprising that the cost-effectiveness analysis comparing 
inpatient and outpatient management strategies surmised that it would never be cost-
effective to treat a woman with mild-moderate disease in the inpatient setting [10].
Even though the Centers for Disease Control and Prevention recommends non-judgmental, 
developmentally appropriate approaches to STI treatment in adolescents, [11] the current 
recommendations are silent on how to effectively translate the available findings to the care 
of the young adolescent girl with PID. More specifically, the guidelines fail to consider the 
limitations on generalizability of the PEACH trial as an efficacy study with high refusal rates 
and differential participation by adolescents or the fact that women in both arms of the trial 
had unacceptably poor outcomes. Multiple studies have also demonstrated that the 
development of PID is associated with increased risk-taking behaviors, that youth have poor 
adherence to the CDC outpatient recommendations for self-care, and that adolescents who 
have recurrent PID are at increased risk for adverse sequelae [12–14]. While adherence to 
the CDC guidelines by clinicians is another major problem in the United States [14–16], the 
recommendations have become less directive due to the absence of more cost-effective 
alternatives [17,18]. The lack of direction with regard to management of adolescents who are 
by definition at-risk because of barriers to self-care and follow-up care leaves clinicians 
struggling for consensus on management of adolescent patients [19].
The quandary posed by the observed treatment and reproductive health outcomes for 
adolescents with PID can only be addressed by additional research that is both adolescent-
focused and designed to develop an alternative cost-effective strategy (figure 1). Further, 
designing alternative approaches that are acceptable to providers and consumers of STI/PID-
related services may allow us to increase patient adherence to reduce adverse outcomes. Use 
Trent et al. Page 2
Med Ther Med Reprod Gynecol Endocrinol. Author manuscript; available in PMC 2019 May 22.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
of community health nurses (CHN) for clinical follow-up has been shown to be an effective 
strategy to improve clinical outcomes in adolescents at risk for other adverse reproductive 
health (e.g. pregnancy) outcomes [20] and may meet the needs of this vulnerable population 
affected by PID. The objective of this study is to determine consumers′willingness-to-pay 
(WTP) for follow-up PID services by physicians versus CHNs, to examine the differences in 
WTP by consumer type, and to examine differences in health-provider predicted consumer 
WTP values and actual consumer WTP values as a first step in identifying an acceptable that 
could potentially fill this void in adolescent health care.
Methods
The methods for this Johns Hopkins Medicine Institutional Review Board approved study 
have previously been described elsewhere, but will be briefly reviewed in this section [21].
Three groups of English-speaking participants were recruited. Croup 1 consisted of 
adolescent girls ages 15- years of age, group 2 consisted of adults (≥18 years) who have 
raised an adolescent and/or are currently parenting an adolescent (>12 years), and the final 
group consisted of clinicians (physicians, nurse practitioners, and physician assistants) who 
a) care for adolescents in clinical practice and b) are in a position to make decisions 
regarding patient disposition after a diagnosis of PID. The term parent includes biological 
parents and surrogate parents (foster parents, adoptive parents, and those parenting otherwise 
through kinship ties (e.g. aunts/uncles, older siblings). Male adolescents, non-clinician 
adults who had not experienced adolescent parenting, clinicians who did not routinely make 
decisions about patient disposition, individuals who were unable to communicate with staff 
due to cognitive or other mental impairment were excluded from the study.
Consumers of adolescent health services (adolescents and parents) were recruited from an 
academic multi-specialty practice (which included an adolescent medicine group) and five 
local school-based health clinics in a large urban community on the East Coast of the United 
States. The community is situated in a wealthy and progressive state with a vibrant history 
and significant academic resources; however, the city is also characterized by significant 
income inequality and high STI incidence among its citizens [22,23]. Given the national 
shortage of adolescent health care providers [24] adolescent-serving clinicians were 
recruited both locally and from the listserves of national organizations serving professionals 
engaged in adolescent health service delivery to improve sample size.
Using a general population approach, all participants completed a web-based survey 
programmed for data collection after providing online consent for human sub- jects
′research. Survey questions were grounded in the contingent valuations method (CVM), 
which uses direct questions to estimate monetary values for services. As such individuals 
were asked to provide demographic information and their maximum WTP for services in 
response to a specific hypothetical outpatient PID scenario. In this instance, we inquired 
regarding the co-payments for physicians or community health nurse for delivery of post-
PID clinical services using the following scenario:
“Imagine a 15-year old girl with pelvic inflammatory disease (PID) that does not 
require a hospital stay for antibiotic treatment. The patient will need to take 
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antibiotic pills for 14 days to treat it. She will also need to notify her sexual partner, 
return to the clinic within 72 hours for care, and abstain from sexual intercourse 
during treatment. She will have pain for about 7 days, with the pain mainly in the 
lower abdomen. It will interfere with daily activity, work, sleep, and family 
relations. Having sex is usually painful, and fever, nausea, and vaginal discharge 
are often a part of the illness. She will be able to eat and drink pretty much as usual. 
She has a very small chance of developing complications that could require a 
hospital stay and possibly an operation. Long-term problems with pain, difficulty 
getting pregnant, or with tubal pregnancy could occur, even if she is treated. 
However, she will probably return to her usual health once the illness goes away, 
but will have some chance of getting PID again in the future. Patients need to be 
checked by a health provider within 72 hours of starting treatment. There are two 
ways that this follow-up can be done : 1) Home visitation by a community health 
nurse; 2) Patient comes to clinic to see their clinical provider. Although health 
insurance will pay for most of the costs of follow-up, the patient may still have to 
make a co-payment for service.”
Participants were then asked about their willingness to pay a co-payment for physician and 
community health nursing services. In each question a low-high ping-pong method [25] was 
used to elicit the maximum WTP. Consumers (adolescents and parents) were asked to 
provide the maximum WTP for themselves and clinicians were asked to estimate the 
maximum WTP for consumers.
All data from the web survey were uploaded into an online database for analysis. Data from 
participants who did not complete the survey was not saved per the consent process and 
study procedures. We report the maximum WTPs as « WTP. » This analysis of data focused 
on continuous WTP variables in dollars for physician versus community health nurse (CHN) 
services. Mean and median WTP for each clinical scenario and WTP variance by 
perspective (parent, patient, and provider) was computed. Differences in WTP were 
analyzed using linear regression analyses. Statistical analyses were performed in SPSS.
Results
Participants comprised 121 parents, 134 adolescents, and 102 clinicians who serve 
adolescents. Eighty-nine percent of the parents were mothers, 76 % were employed outside 
of the home, and 25 % of parents had a prior history of STIs. The mean income for parents 
was $39,700 (SD $21,400). Twenty-three percent of the adolescents were employed and 
20 % had a prior history of STIs. Clinicians were mostly women, devoted 70 % of their 
practice to the care of adolescents, 62 % of their practices served low income patients based 
on insurance status, and 21 % of the patients care was related to STI treatment.
The mean WTP for physician services was $16 (SD $16.9) according to clinicians, $81.9 
($34.0) for parents, and $ 72 (SD $ 39.1) for adolescents. The mean WTP for CHN services 
was $13.6 (SD $17.4) as predicted by clinicians, $62.4 (SD $44.1) for parents, and $49.7 
(SD $44) for adolescents. Adolescents were willing to pay $36 more (95 % Cl : $27.9–44.3) 
for community health nursing care and parents were willing to pay $48 more dollars (95 % 
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Cl: $40.3-$57.4) than physician’s predicted. There were no significant differences in 
adolescent and parents WTP for physician or nursing services Consumers (adolescents & 
parents) WTP for physician PID services were on average $18.50 higher than CHN PID 
services (p = 0.01). Using physician estimates for WTP as the reference group, adolescents 
were willing to pay $56 more (95 % Cl : $48.6-$63.4) for physician care and parents were 
willing to pay $66 more (95 % Cl : $59.0-$72.8) than physician′s predicted.
Conclusion
This study demonstrates that while adolescents and parents clearly prefer physician follow-
up for PID, they are open to CHN follow-up visits based on the mean WTP for CHN visits. 
Since WTP also reflects the value that individuals place on a service, our data demonstrate 
that clinicians consistently underestimate the value the consumers place on clinical service 
for PID. Given poor adherence to physician follow-up, additional research evaluating 
alternate models of care including the effectiveness of CHN visits for PID follow-up care is 
warranted.
Home nurse visitation interventions have been effective in improving several maternal and 
child outcomes, particularly when targeting parenting skills education and family planning. 
The impact of home nurse visiting interventions have been reported to prevent child abuse 
and neglect, children’s mental health problems and infant mortality [26, 27], reduce repeat 
pregnancy rates [28] and improve utilization of resources including prenatal care and WIC 
for pregnant and parenting adolescents [20]. One specific adolescent pregnancy home nurse 
intervention, Teen Parenting Partnership (TPP) Program, demonstrated that adherence to 
appointments for prenatal care were significantly higher in the home nurse group as 
compared to the comparison group suggesting that interventions that increase an 
adolescent’s access to resources will enhance their appropriate health care utilization and 
promote risk- reducing behavior [29].
To our knowledge, this study is the first to begin to fill a void of available data on consumer 
preferences and provider perception of consumer preferences related to adolescent STI-care 
and to offer a viable alternative towards improving outcomes [30]. There is sufficient 
precedent in the literature to suggest such differences paired with additional cost-
effectiveness outcomes may lead to policy shifts related to care management by initiating 
discussion across the key stakeholder groups [31–33], Integration of the parental perspective 
is particularly important because adolescents with PID are experiencing transition in 
autonomy and often seek services without the assistance of an involved adult and by law are 
able to make decisions about their care regardless of developmental status. The benefit of 
this approach is that we acknowledge the importance of the adolescent perspective while 
demonstrating and integrating the value parents place on PID care as key stakeholders.
Our findings must be considered in light of several general study limitations. These data 
were collected from adolescents and parents in pediatric and adolescent clinical settings in a 
single urban community in the United States, thus findings may not be generalizable to other 
dissimilar communities. However, these findings are important given the significant health 
disparities faced by urban adolescents. The estimates can also be used to provide better 
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ranges for adolescent-related economic analyses. Although the study recruited a few girls 
with a history of PID, data are reflective of the perspective of the general community of 
medical care users. This view is preferred compared with use of valuations from only those 
affected by a disorder in economic analyses. Clinicians′valuations may have been biased by 
the current realities of co-payments thus lowering the predicted values for parents. CVM 
values from WTP are also controversial because it is survey data and not observed 
behavioral outcomes and it is hard for policymakers to spend dollars using CVM data. CVM 
however, is the mostly widely accepted method for estimating total economic value for non-
use and can also be used to estimate the ultimate value for goods and services.
Implications
PID is a prevalent and costly reproductive health problem amongst adolescents in the United 
States. Adolescents with PID continue to experience adverse reproductive health outcomes 
regardless of inpatient or outpatient treatment, suggesting that the value of follow-up is not 
associated with the location or type of treatment setting, but rather who delivers treatment. 
Adolescents and parents are willing to pay higher than average co-payments to ensure that 
necessary follow-up care is received for PID, but adolescent and parent WTP for both CHN 
and physician services is significantly higher than the consumer WTP predicted by 
clinicians. Despite potential inflation of WTP payments using CVM, the WTP values from 
the study suggest that consumers think that follow-up care for PID is important and they are 
willing to have STI follow-up in their homes. Additional research exploring the effectiveness 
of community health nursing and other evidence-based interventions to improve PID care in 
the United States is warranted.
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Figure 1. 
Strategic Approach to PID Management Considering Cost-effectiveness.
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